Abstract:Highlights . The features of subsets of monocytes in combination with the levels of desquamated endotheliocytes, endothelial damage and regeneration mediators and progenitor cell migration-enhancing factors in patients with coronary heart disease and with/without ischemic cardiomyopathy were analyzed. For the first time it was shown that in patients with ischemic cardiomyopathy, compared with CHD patients without cardiomyopathy, higher desquamation of the endothelium is associated with a deficiency of non-classical monocytes and reduced migration of progenitor endothelial cells (VEGFR2+-monocytes) with regenerative potential across the bone marrow due to a deficiency of the HIF-1α mediator in the blood. Background . The development of ischemic cardiomyopathy (ICM) is an understudied process, and one of its elements may be insufficient regeneration of blood vessels due to an imbalance of subsets of monocytes in the blood. Aim . To assess subsets of monocytes and desquamated endothelial cells in combination with endothelial damage and regeneration mediators in the blood of patients with coronary heart disease (CHD) and with/without ICM. Methods . The study included 30 patients with ICM, 22 patients with coronary heart disease without cardiomyopathy aged 55–69 years, and 18 healthy donors. In whole blood, the populations of CD45 – CD146 + desquamated endothelial cells and progenitor endothelial cells related to CD14+VEGFR2+ monocytes, intermediate CD14 ++ CD16 + and non-classical CD14 + CD16 ++ monocytes were assessed by flow cytometry using the appropriate monoclonal antibodies (BD Biosciens, USA). In blood plasma, the levels of hypoxia-inducible factor HIF-1α, monocyte chemoattractant protein MCP-1 and matrix metalloproteinase MMP-9 were assessed by enzyme immunoassay. The results of the analysis were considered significant at p<0.05. Results . The number of progenitor and desquamated endothelial cells was increased in both groups of patients with coronary artery disease. At the same time, in patients with ICM, the number of progenitor endothelial cells did not reach the number noted in patients with CHD without cardiomyopathy, while the number of desquamated endothelial cells reached the number noted in CHD patients without cardiomyopathy. There was a deficiency of non-classical monocytes and HIF-1α in the blood of patients with ICM, and an excess of intermediate monocytes and MCP-1 was observed in CHD patients without cardiomyopathy. The concentration of MMP-9 in patients with CHD corresponded to the norm, regardless of the presence of ICM. Conclusion . In ICM, in contrast to CHD without cardiomyopathy, vascular damage is associated with a deficiency of nonclassical monocytes and reduced endothelial repair due to insufficient migration of progenitor endothelial cells across the bone marrow due to HIF-1α deficiency in the blood.

[Characteristics of hemorheological processes in patients with chronic obstructive bronchitis combined with ischemic heart disease]

[The characteristics of disorders of intracardiac hemodynamics and hemorheology in pulmonary heart failure]

Features of cerebral blood flow in patients with chronic obstructive pulmonary disease associated with hypertension

[Viscosity of blood and plasma in patients with single- and multi-vascular coronary heart disease]

[Hemorrheological status in patients with silicosis and its clinical significance]

Circulating endothelial cells in stable severe chronic obstructive pulmonary diseases

Activity of inflammation in patients with chronic obstructive pulmonary disease and anemia

Subclinical cardiovascular changes in chronic obstructive pulmonary disease patients: Doppler ultrasound evaluation

Imbalance of Endogenous Hydrogen Sulfide and Homocysteine in Chronic Obstructive Pulmonary Disease Combined with Cardiovascular Disease

Clinical Value of Blood Rheology Detection at Acute Stage of Chronic Polmonary Heart Disease

Blood monocytes in maintaining the balance of vascular endothelial injury and repair process in ischemic cardiomyopathy

THE EFFECT OF LOW MOLECULAR WEIGHT HEPARIN SODIUM IN THE TREATMENT OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE COMORBID WITH PULMONARY HEART DISEASE ON PROMOTING THE BALANCE OF BLOOD VESSELS

Effect of blood viscosity on the hemodynamic significance of coronary artery stenosis

Expressions of brain natriuretic peptide, fibrinogen,hypersensitive C-reactive protein, D-Dimer and arterial blood gas analysis in acute exacerbation of chronic obstructive pulmonary disease patients complicated with pulmonary hypertension

Changes of Small Pulmonary Vascular in Patients with Acute Exacerbation of COPD and Clinical Value

Hypertrophic remodelling of retinal arterioles in patients with congestive heart failure

Influence of heart failure (HF) comorbidity in chronic obstructive pulmonary disease (COPD) and isolated forms of HF and COPD on cardiovascular function during hospitalization

[Image and Hemodynamical Features of Pulmonary Artery Branches in COPD with Pulmonary Artery Hypertension].

Ischemic heart disease and chronic obstructive pulmonary disease: the topical problem of comorbidity in internal medicine

Study of Hemorheology and Prothrombin Chart in Cerebral Infarction and Cerebral Hemorrhage Patients with Blood Stagnation

Sublingual functional capillary rarefaction in chronic heart failure